KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
EBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsShares IssuedShares OutstandingShares Outstanding
Ratios

Palvella Therapeutics (PVLA) Shares Outstanding (2016 - 2026)

Palvella Therapeutics has reported Shares Outstanding over the past 10 years, most recently at $1.8 million for Q4 2022.

  • Quarterly Shares Outstanding fell 97.55% to $1.8 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $1.8 million through Dec 2022, down 97.55% year-over-year, with the annual reading at $1.8 million for FY2022, 97.55% down from the prior year.
  • Shares Outstanding was $1.8 million for Q4 2022 at Palvella Therapeutics, down from $74.4 million in the prior quarter.
  • Over five years, Shares Outstanding peaked at $74.4 million in Q3 2022 and troughed at $11000.0 in Q4 2019.
  • The 5-year median for Shares Outstanding is $54.0 million (2018), against an average of $41.4 million.
  • Year-over-year, Shares Outstanding tumbled 99.97% in 2020 and then surged 529171.43% in 2022.
  • A 5-year view of Shares Outstanding shows it stood at $54.2 million in 2018, then increased by 1.96% to $55.2 million in 2019, then tumbled by 99.97% to $14000.0 in 2020, then surged by 515771.43% to $72.2 million in 2021, then crashed by 97.55% to $1.8 million in 2022.
  • Per Business Quant, the three most recent readings for PVLA's Shares Outstanding are $1.8 million (Q4 2022), $74.4 million (Q3 2022), and $74.3 million (Q2 2022).